These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6404132)

  • 1. Proteinuria and nonsteroid anti-inflammatory drugs.
    Michielsen P; Varenterghem Y
    Adv Nephrol Necker Hosp; 1983; 12():139-50. PubMed ID: 6404132
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of nonsteroidal anti-inflammatory drugs on proteinuria.
    Vriesendorp R; Donker AJ; de Zeeuw D; de Jong PE; van der Hem GK; Brentjens JR
    Am J Med; 1986 Aug; 81(2B):84-94. PubMed ID: 3529951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
    Lagrue G; Masbernard A; Giudicelli C; Hirbec G
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1434-9. PubMed ID: 4614821
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of indomethacin on glomerular permeability in the nephrotic syndrome.
    Tiggeler RG; Hulme B; Wijdeveld PG
    Kidney Int; 1979 Sep; 16(3):312-21. PubMed ID: 529678
    [No Abstract]   [Full Text] [Related]  

  • 5. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of nonsteroidal anti-inflammatory drugs on glomerular filtration of proteins and their therapeutic utility.
    Remuzzi A; Remuzzi G
    Semin Nephrol; 1995 May; 15(3):236-43. PubMed ID: 7631050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
    Takano T; Cybulsky AV; Cupples WA; Ajikobi DO; Papillon J; Aoudjit L
    J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of kidney diseases with non-steroid anti-inflammatory drugs. I. Antiproteinuric effects of indomethacin].
    Hamada A
    Nihon Jinzo Gakkai Shi; 1975 Dec; 17(12):973-94. PubMed ID: 1241989
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term effects of antihypertensive agents on proteinuria and renal function.
    Maki DD; Ma JZ; Louis TA; Kasiske BL
    Arch Intern Med; 1995 May; 155(10):1073-80. PubMed ID: 7748051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of indometacin for treating diffuse glomerulonephritis under experimental and clinical conditions.
    Vihert AM; Glezer GA; Megrelishvili RI; Ryff IM
    Arzneimittelforschung; 1973 Jul; 23(7):991-6. PubMed ID: 4800460
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-proteinuria effects of nonsteroidal anti-inflammatory drugs in patients with nephrotic syndrome: an illusion or a read improvement?].
    Stosić Z; Sedlak V; Felle D; Curić S; Ubavić M; Vodopivec S
    Med Pregl; 1995; 48(5-6):155-8. PubMed ID: 7565334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the filtration and reabsorption barrier of the kidneys of the rat after administration of nonsteroidal anti-inflammatory preparations].
    Grom VV
    Arkh Anat Gistol Embriol; 1986 Apr; 90(4):55-9. PubMed ID: 3718253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Side effects of nonsteroidal anti-inflammatory drugs on kidney function].
    Androsova SO; Kutyrina IM
    Revmatologiia (Mosk); 1983; (2):57-61. PubMed ID: 6353518
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary excretion of fibrinogen-fibrin-related antigen in glomerulonephritis: effect of indomethacin.
    Dotremont G; Vermylen J; Donati MB; Van Damme B; Michielsen P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):829-44. PubMed ID: 4803317
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis.
    Kahvecioglu S; Dilek K; Akdag I; Gullulu M; Demircan C; Ersoy A; Yurtkuran M
    Nephrology (Carlton); 2006 Jun; 11(3):232-7. PubMed ID: 16756637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
    Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
    Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenously administered frusemide increases glomerular permeability.
    Ala-Houhala I; Vapaatalo H; Pasternack A
    Clin Sci (Lond); 1987 Oct; 73(4):365-70. PubMed ID: 3665358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of nonsteroid anti-inflammatory agents on the permeability of histohematic barriers].
    Berezniakova AI
    Farmakol Toksikol; 1983; 46(4):61-5. PubMed ID: 6684593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition and the combination of a beta blocker and a diuretic are equally effective in lowering proteinuria in patients with glomerulonephritis.
    Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1993; 8(9):808-13. PubMed ID: 8255512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modification of renal hemodynamics and proteinuria in patients with arterial hypertension and kidney diseases].
    Risler T; Erley CM
    Z Kardiol; 1993; 82 Suppl 4():39-44. PubMed ID: 7908476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.